Committee On Non-Prescription Drugs To Deliberate On Epadel
This article was originally published in PharmAsia News
Executive Summary
Japan’s Ministry of Health Labor and Welfare has entered Epadel (ethyl eicosapentaenoic acid), a drug for the treatment of hyperlipidemia, on the list of deliberated items for the Pharmaceuticals Affairs and Food Sanitation Council’s Committee On Non-Prescription Drugs meeting to be held Oct. 17.